26 201

Cited 0 times in

Antinuclear Antibodies in Patients with Behc、et´s Disease

DC Field Value Language
dc.contributor.author천, 은영-
dc.contributor.author박, 상건-
dc.contributor.author조, 영훈-
dc.contributor.author이, 주희-
dc.contributor.author이, 광훈-
dc.contributor.author방, 동식-
dc.contributor.author이, 은소-
dc.date.accessioned2012-03-09T05:14:48Z-
dc.date.available2012-03-09T05:14:48Z-
dc.date.issued2004-
dc.identifier.issn0494-4739-
dc.identifier.urihttp://repository.ajou.ac.kr/handle/201003/6050-
dc.description.abstractBackground: Behtiet´s disease has features consistent with an immunopathogenic mechanism, but the autoreactivity in pathogenesis is unclear.

Objective: This study was to investigate the association of antinuclear antibodies (ANA) with Behcet´s disease.

Methods: The patients in this study were diagnosed at Severance Hospital Behcet´s Disease Specialty Clinic from May, 1998 to May, 2002. We evaluated the frequency, titers and immunofluorescence patterns of ANA in patients with Behcet´s disease, and compared the frequency with a healthy control group. According to the positivity of ANA, we compared the frequency of minor symptoms to investigate the association of the severity of disease with ANA.

Results:

1. Of the 554 cases of Behtcet´s disease, 46 cases (8.3%) were ANA positive, however, of the 271 cases of healthy control group, only 5 cases (1.8%) were ANA positive. (p=0.0003)

2. In ANA titers 38 cases (82.6%) showed low titer (1:40+, 1:160-), 5 cases (10.9%) intermediate titer (1:160+, 1:640-), and 3 cases high titer (>1:640+). There was no significant difference in intermediate and high titers between complete (17.9%) and incomplete type (14.3%).

3. In immunofluorescence patterns of ANA, 17 cases (37%) were speckled pattern, 5 cases (10.9%) homogeneous pattern, 3 cases (6.5%) centromere pattern. 2 cases (4.3%) nucleolar pattern and 19 cases (41.3%) unknown pattern.

4. Of 508 cases with negative ANA patients, 272 cases (53.5%) had minor symptoms, however, of 46 cases with positive ANA patients, 14 cases (30.4%) had minor symptoms (p=0.0027).

Conclusion: From this study ANA was more prevalent in Behcet´s disease. However, it was not related to severity of disease and most of them were low titer. ANA, herein, might play a minor role in pathogenesis of Beh~et´s disease.
-
dc.language.isoko-
dc.titleAntinuclear Antibodies in Patients with Behc、et´s Disease-
dc.title.alternative베체트병(Behc、et´s disease) 환자에서 항핵항체(Antinuclear antibody)의 발현에 관한 연구-
dc.typeArticle-
dc.identifier.urlhttp://kmbase.medric.or.kr/Main.aspx?d=KMBASE&m=VIEW&i=0363220040420050545-
dc.subject.keywordBehc、ets disease-
dc.subject.keywordAntinuclear Antibody-
dc.type.localJournal Papers-
dc.citation.titleKorean journal of dermatology-
dc.citation.title대한피부과학회지-
dc.citation.volume42-
dc.citation.number5-
dc.citation.date2004-
dc.citation.startPage545-
dc.citation.endPage550-
dc.identifier.bibliographicCitationKorean journal of dermatology, 42(5):545-550, 2004-
Appears in Collections:
Journal Papers > School of Medicine / Graduate School of Medicine > Dermatology
Files in This Item:
Korean journal of dermatology_42(5)_545-550.pdfDownload

qrcode

해당 아이템을 이메일로 공유하기 원하시면 인증을 거치시기 바랍니다.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse